Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-040108

EVP and General Counsel sold 1,329 shares at $100.00 ($132,900)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and General Counsel 2021-06-10 Sale −1,329 $100.00 $132,900 28,668 D: show line 1 in the form
Open-market sales · 1,329 sh · avg $100.00 · $132,900
Loading xslF345X03/doc4.xml…